These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8699502)

  • 1. Nifedipine-induced gingival enlargement around dental implants: a clinical report.
    Silverstein LH; Koch JP; Lefkove MD; Garnick JJ; Singh B; Steflik DE
    J Oral Implantol; 1995; 21(2):116-20. PubMed ID: 8699502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gingival hyperplasia during treatment with nifedipine].
    Bokor-Bratić M; Vucković N; Selaković S
    Med Pregl; 1998; 51(9-10):445-8. PubMed ID: 9863337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with the treatment of gingival hyperplasia induced by calcium channel blocking agents].
    Keglevich T; Benedek E; Gera I
    Fogorv Sz; 1999 Dec; 92(12):363-72. PubMed ID: 10641419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of nifedipine-induced gingival hyperplasia. A case report.
    Abitbol TE; Rosenfeld-Abitbol M
    N Y State Dent J; 1996; 62(7):34-7. PubMed ID: 8824115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine-induced gingival overgrowth: remission following non-surgical therapy.
    Ciantar M
    Dent Update; 1996 Nov; 23(9):374-7. PubMed ID: 9452616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine-associated gingival overgrowth: a survey of the literature and report of four cases.
    Deen-Duggins L; Fry HR; Clay JR; Turner JR
    Quintessence Int; 1996 Mar; 27(3):163-70. PubMed ID: 9063228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodontal management of nifedipine-induced gingival overgrowth: a case report and review of the pertinent literature.
    Hapak L
    Oral Health; 1994 Oct; 84(10):15-7, 20-1; quiz 22. PubMed ID: 8779668
    [No Abstract]   [Full Text] [Related]  

  • 8. Nifedipine-induced gingival hyperplasia: non-surgical management of a patient.
    Naidoo LC; Stephen LX
    Spec Care Dentist; 1999; 19(1):29-34. PubMed ID: 10483458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced gingival hyperplasia].
    Nohl F; Ferrari P
    Ther Umsch; 1998 Sep; 55(9):573-5. PubMed ID: 9789475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin hyperplasia occurring in relation to titanium implants: a clinical report.
    Chee WW; Jansen CE
    Int J Oral Maxillofac Implants; 1994; 9(1):107-9. PubMed ID: 8150508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report.
    Jackson C; Babich S
    N Y State Dent J; 1997 Jan; 63(1):46-8. PubMed ID: 9046179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study.
    Ellis JS; Seymour RA; Steele JG; Robertson P; Butler TJ; Thomason JM
    J Periodontol; 1999 Jan; 70(1):63-7. PubMed ID: 10052772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine-induced gingival hyperplasia.
    Burkes EJ; Jacoway JR; Stevens DT; Braddock ME
    J Tenn Dent Assoc; 1992 Apr; 72(2):35-7. PubMed ID: 1625455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical and histological comparative study of the effect of nifedipine and phenytion on human gingiva.
    Shoieb MA; Fathy LM; Abu-el-Dahab O; el-Sherbiny MM
    Egypt Dent J; 1993 Oct; 39(4):555-8. PubMed ID: 9588123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the relation of nitric oxide to nifedipine-induced gingival hyperplasia and impaired submandibular glands function in rats in vivo.
    Rezaie S; Rezaie A; Minaiee B; Khorasani R; Abdollahi M
    Fundam Clin Pharmacol; 2005 Feb; 19(1):65-71. PubMed ID: 15660961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nifedipine induced gingival hyperplasia].
    Gonzalez-Jaranay M; Mesa F
    Rev Eur Odontoestomatol; 1991; 3(2):127-30. PubMed ID: 1867732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.
    Westbrook P; Bednarczyk EM; Carlson M; Sheehan H; Bissada NF
    J Periodontol; 1997 Jul; 68(7):645-50. PubMed ID: 9249636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine-induced gingival hyperplasia.
    Silverstein LH; Koch JP; Shatz PC
    Am Fam Physician; 1996 Mar; 53(4):1069-70. PubMed ID: 8629555
    [No Abstract]   [Full Text] [Related]  

  • 19. The patient with hypertension.
    Riley CK; Terezhalmy GT
    Quintessence Int; 2001 Oct; 32(9):671-90. PubMed ID: 11695136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of gingival hyperplasia caused by calcium antagonists in continuous ambulatory peritoneal dialysis patients.
    Shouda J; Nakamoto H; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 1999; 15():153-5. PubMed ID: 10682092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.